(Q79794344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Philippe Fagnoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Samuel Limat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Loïc Chaigneau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Emmanuel Guardiola

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Stéphanie Briaud

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bernard Schmitt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Yacine Merrouche

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Marie-Christine Woronoff-Lemsi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

27 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

1030-1037

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

25 December 2019

cites work

1 reference

12 December 2020

Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors

1 reference

12 December 2020

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

12 December 2020

Quality-of-life measures as providers of information on value-for-money of health interventions. Comparison and recommendations for practice

1 reference

12 December 2020

Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life

1 reference

12 December 2020

Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.

1 reference

12 December 2020

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making

1 reference

12 December 2020

Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials

1 reference

12 December 2020

Willingness to pay for a QALY: theoretical and methodological issues

1 reference

12 December 2020

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo

1 reference

12 December 2020

Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia

1 reference

12 December 2020

Generalisation from phase III clinical trials: survival, quality of life, and health economics.

1 reference

12 December 2020

[Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003]

1 reference

12 December 2020

Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy

1 reference

12 December 2020

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

12 December 2020

The level of haemoglobin in anaemic cancer patients correlates positively with quality of life

1 reference

12 December 2020

Factors influencing quality of life in cancer patients: anemia and fatigue.

1 reference

12 December 2020

A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries

1 reference

12 December 2020

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group

1 reference

12 December 2020

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia

1 reference

12 December 2020

Clinical and economic impact of epoetins in cancer care

1 reference

12 December 2020

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.

1 reference

12 December 2020

Management of anaemia in patients with breast cancer: role of epoetin

1 reference

12 December 2020

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

1 reference

12 December 2020

The impact of anaemia and its treatment on employee disability and medical costs

1 reference

12 December 2020

Systematic overview of cost-utility assessments in oncology

1 reference

12 December 2020

Erythropoietin for anaemia in cancer patients

1 reference

12 December 2020

10.1007/S00520-006-0062-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16802128%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference